Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phenobarbital tolerance and physical dependence: chronically equivalent dosing model.

M H Gay, G P Ryan, N R Boisse

    European Journal of Pharmacology
    |November 11, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Nose to back: compatibility of nasal chondrocytes with environmental conditions mimicking a degenerated intervertebral disc.

    European cells & materials·2019
    Same author

    Identification of metabolites of [1,2,3-(13)C]Propargyl alcohol in rat urine by (13)C NMR and mass spectrometry.

    Journal of agricultural and food chemistry·1999
    Same author

    A double-blind, placebo-controlled study comparing mianserin and amitriptyline in moderately depressed outpatients.

    International clinical psychopharmacology·1994
    Same author

    Intravenous flumazenil following acute and repeated exposure to lorazepam in healthy volunteers: antagonism and precipitated withdrawal.

    The Journal of pharmacology and experimental therapeutics·1993
    Same author

    Subjective and behavioral effects of diphenhydramine, lorazepam and methocarbamol: evaluation of abuse liability.

    The Journal of pharmacology and experimental therapeutics·1992
    Same author

    Tolerance and physical dependence to a short-acting benzodiazepine, midazolam.

    The Journal of pharmacology and experimental therapeutics·1990
    Same journal

    Astaxanthin inhibits platelet-mediated thrombosis via suppression of bidirectional αIIbβ3 signaling.

    European journal of pharmacology·2026
    Same journal

    Repurposing of alogliptin to mitigate experimentally-induced ulcerative colitis and its associated pulmonary injury in rats through regulating inflammatory, necroptotic, and ER stress pathways.

    European journal of pharmacology·2026
    Same journal

    Erianin ameliorates liver fibrosis through the PRDX3/NLRX1 axis.

    European journal of pharmacology·2026
    Same journal

    4-Octyl itaconate attenuates renal calculi formation by inhibiting ferroptosis and oxidative stress via the Nrf2-HO-1/SLC7A11 axis.

    European journal of pharmacology·2026
    Same journal

    VER155008 rescues cognitive impairment in P301S tauopathy mice by promoting HSPA8-mediated lipophagy.

    European journal of pharmacology·2026
    Same journal

    Okanin alleviates osteoarthritis by suppressing oxidative stress and pyroptosis via Nrf2/HO-1 activation.

    European journal of pharmacology·2026
    See all related articles

    This study developed a rat model for phenobarbital tolerance and dependence using a specific dosing method. Results show that chronic phenobarbital use leads to physical dependence and withdrawal symptoms in rats, similar to humans.

    Area of Science:

    • Pharmacology
    • Neuroscience
    • Animal Models

    Background:

    • Phenobarbital is a barbiturate with sedative-hypnotic properties.
    • Understanding tolerance and physical dependence is crucial for clinical use.
    • Developing reliable animal models aids in studying drug effects.

    Purpose of the Study:

    • To establish a rat model for phenobarbital tolerance and physical dependence.
    • To characterize the abstinence syndrome following chronic phenobarbital administration.
    • To compare tolerance and dependence characteristics across different treatment durations.

    Main Methods:

    • Rats received daily oral doses of sodium phenobarbital for 35 days.
    • Dosing was adjusted to maintain consistent central nervous system (CNS) depression.

    Related Experiment Videos

  • Abrupt cessation of treatment was followed by observation for withdrawal signs.

    • Main Results:

    • A reproducible abstinence syndrome, indicating physical dependence, was observed upon drug cessation.
    • Withdrawal signs (motor, autonomic, behavioral) emerged within 12-24 hours and resolved by 12 days.
    • Tolerance developed by day 10, but the abstinence syndrome was more severe after 35 days than after 10 days of treatment.

    Conclusions:

    • The developed rat model effectively demonstrates phenobarbital tolerance and physical dependence.
    • The findings suggest that longer durations of chronic phenobarbital treatment may lead to more severe physical dependence.
    • The observed characteristics of tolerance and dependence in rats align with those reported in humans.